Next Article in Journal
Seaweed Phenolics: From Extraction to Applications
Next Article in Special Issue
Sponge-Derived 24-Homoscalaranes as Potent Anti-Inflammatory Agents
Previous Article in Journal
13-Acetoxysarcocrassolide Exhibits Cytotoxic Activity against Oral Cancer Cells through the Interruption of the Keap1/Nrf2/p62/SQSTM1 Pathway: The Need to Move Beyond Classical Concepts
Previous Article in Special Issue
Modulation of Glial Responses by Furanocembranolides: Leptolide Diminishes Microglial Inflammation in Vitro and Ameliorates Gliosis In Vivo in a Mouse Model of Obesity and Insulin Resistance
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Briarenols Q–T: Briaranes from A Cultured Octocoral Briareum stechei (Kükenthal, 1908)

1
Graduate Institute of Marine Biology, National Dong Hwa University, Pingtung 944401, Taiwan
2
National Museum of Marine Biology and Aquarium, Pingtung 944401, Taiwan
3
Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan
4
Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 804201, Taiwan
5
Institute of BioPharmaceutical Sciences, National Sun Yat-sen University, Kaohsiung 804201, Taiwan
6
Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung 404333, Taiwan
7
Chinese Medicine Research and Development Center, China Medical University Hospital, Taichung 404394, Taiwan
8
Department of Nursing, Meiho University, Pingtung 912009, Taiwan
9
Research Center for Chinese Herbal Medicine, Research Center for Food and Cosmetic Safety, Graduate Institute of Healthy Industry Technology, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 333324, Taiwan
10
Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan
11
Chinese Herbal Medicine Research Team, Healthy Aging Research Center, Chang Gung University, Taoyuan 333323, Taiwan
12
Department of Anaesthesiology, Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan
13
Department of Chemical Engineering, Ming Chi University of Technology, New Taipei City 243303, Taiwan
14
Department of Biological Science & Technology, Meiho University, Pingtung 912009, Taiwan
15
Department of Food Science and Nutrition, Meiho University, Pingtung 912009, Taiwan
16
Department of Neurosurgery, Antai Medical Care Corporation Antai Tian-Sheng Memorial Hospital, Pingtung 928004, Taiwan
17
Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 807378, Taiwan
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Mar. Drugs 2020, 18(8), 383; https://doi.org/10.3390/md18080383
Submission received: 6 July 2020 / Revised: 17 July 2020 / Accepted: 20 July 2020 / Published: 24 July 2020
(This article belongs to the Special Issue Marine Compounds and Inflammation II)

Abstract

:
Our continuous chemical study of a cultured octocoral Briareum stechei led to the isolation of four new briarane diterpenoids, briarenols Q–T (14). The structures of new metabolites 14 were established by spectroscopic methods, and compounds 3 and 4 were found to inhibit the generation of inducible nitric oxide synthase (iNOS) from RAW 264.7 stimulated by lipopolysaccharides (LPS).

1. Introduction

Since 1950, the nucleoside spongothymidine, which is obtained from the Caribbean sponge Cryptotethia [1], and the derivative of this nucleoside 1-β-D-arabinofuranosylcytosine (Ara-C) have been approved as the first marine-origin clinical medications used in treatment of leukemia in 1969. Marine natural products (MNPs) from marine invertebrates, such as Porifera and Cnidaria, played important roles in drug discovery due to their complex structures and interesting bioactivities [2,3]. Most of the pharmaceutical coral reef organisms are claimed to be endangered species. In order to protect natural populations and habitats of these marine organisms from overexploitation and to support bioactive materials for further study and medicinal use [4], a cultured octocoral Briareum stechei (Kükenthal, 1908), which was previously identified as Briareum excavatum (Nutting, 1911) [5], was studied for its interesting chemical constituents related to briarane-type diterpenoids. Herein, we report on the isolation, structure determination, and anti-inflammatory activity of four unreported isolates, briarenols Q–T (14) (Figure 1).

2. Results and Discussion

The octocoral B. stechei was harvested in an 80 ton culturing tank in April 2016. This target organism was freeze-dried and ground, followed by exhaustive extraction in a mixture of dichloromethane (CH2Cl2) and methanol (MeOH). Normal- and reverse-phase HPLC yielded four new briarane diterpenoids, briarenols Q–T (14).
Briarenol Q (1), [ α ] D 25 +22 (c 0.1, CHCl3), was obtained as an amorphous powder with the molecular formula C27H34O12, based on its positive-mode high-resolution electrospray ionization mass spectrum (HRESIMS) at m/z 573.19426 (calculated for C27H34O12Na+, 573.19425), with 11 indices of hydrogen deficiency (IHDs). The IR spectrum showed the presence of hydroxy (νmax 3408 cm1), γ-lactone (νmax 1783 cm1), and ester carbonyl (νmax 1733 cm1) groups. The 1H, 13C, and heteronuclear single quantum coherence (HSQC) spectra indicated the presence of seven methyls, two sp3 methylenes, six sp3 methines, three sp3 quaternary carbons, two sp2 methines, two quaternary olefinic carbons, and five ester-equivalents (Table 1 and Table 2), accounting for all carbons and 33 of the 34 protons. Two of the sp3 quaternary carbons had 13C chemical shifts at δC 80.8 and 94.0, indicative of an oxygen-bearing quaternary carbon and a hemiketal carbon, respectively. A tetracyclic scaffold was deduced by IHDs, as seven of the 11 unsaturation degrees could be assigned to a pair of carbon–carbon double bonds (δC 138.4, C-5; 128.0, CH-6; 131.1, C-11; 122.0, CH-12) and five esters (δC 164.6, 169.2, 169.7, 173.2, 174.9).
The 1H NMR coupling information in the 1H–1H correlation spectroscopy (COSY) of 1 enabled the identification of four different spin systems, H-2/H2-3, H-6/H-7, H-12/H2-13/H-14, and H-17/H3-18 (Figure 2), which were assembled with the assistance of a heteronuclear multiple-bond correlation (HMBC) experiment. The 2J- or 3J-1H–13C long-range correlations between H-2, H-3α, H-6/C-4, H-3α/C-2, H-9/C-1, and H-9/C-11 permitted elucidation of the main carbon skeleton of 1. A vinyl methyl at C-11 was confirmed by an allylic coupling between H-12 (δH 5.56) and H3-20 (δH 1.96) in the COSY experiment. The 2J- or 3J-1H–13C long-range correlations between H-2, H-3α, H-6/C-4, H-3α/C-2, H-9/C-1, and H-9/C-11 permitted elucidation of the main carbon skeleton of 1. A vinyl methyl at C-11 was confirmed by an allylic coupling between H-12 (δH 5.56) and H3-20 (δH 1.96) in the COSY experiment and by the HMBC between H3-20/C-11 and C-12. The ring junction Me-15 at C-1 was supported by the HMBC between H3-15/C-1, C-2, C-10, C-14, and H-2/C-15. Thus, the methyl-esterified carboxyl group at C-5 was supported by an HMBC between δH 3.81 (3H, s, –OMe), with δC 164.6 (C-16). The acetate ester at C-9 was established by a correlation between H-9 (δH 6.05) and the acetate carbonyl at δC 169.7 observed in the HMBC spectrum. The C-4 hydroxy group was concluded to be a part of a hemiketal constellation on the basis of a characteristic carbon signal at δC 94.0 (a quaternary hemiketal carbon, C-4). An oxygenated quaternary carbon signal at δC 80.8 showed a 3J-coupling with the methyl protons at δH 1.46 (H3-18). In total, 8 of the 12 oxygen atoms in the molecular formula could be accounted for the presence of a γ-lactone, an ester, a hemiketal, and an α,β-unsaturated methyl esterified carboxyl group. Thus, the remaining four oxygen atoms had to be positioned at C-2 and C-14 as acetoxy groups, respectively, as indicated by their 1H and 13C NMR chemical shifts (δH 5.11, 1H, d, J = 7.2 Hz; δC 72.1, CH-2; δH 5.18, 1H, d, J = 4.2 Hz; δC 71.8, CH-14), although no HMBC correlation was observed from H-2 and H-14 to any acetate carbonyl. These findings, together with the HMBC between H-17/C-19 and H3-18/C-17 and C-19, were used to establish the molecular framework of 1.
The stereochemical evaluation of 1 was approached using a nuclear Overhauser effect spectroscopy (NOESY) experiment (Figure 2) and was found to be compatible with that of 1 offered by computer modeling [6] and that obtained from vicinal proton coupling constant analysis. Proton H-10 exhibited correlations with H-2, H-9, and H3-18, while H-14 correlated with H3-15, setting the Me-15 at C-1 as trans to H-10, as observed in all naturally occurring briarane-type diterpenoids [7]. Due to Me-18 at C-17 being α-oriented in the γ-lactone moiety, H-17 should be positioned on the β face. This proton showed a slight correlation with H-7, indicating that H-7 was β-oriented. H-7 showed a correlation with H-6, and a coupling constant (J = 4.8 Hz) was detected between H-7 and H-6, indicating that the dihedral angle between H-6 and H-7 is approximately 60°, and that H-6 is β-oriented. The hydroxy proton at δH 6.11 (OH-4) displayed a light correlation with H-2, setting the hydroxy group at C-4 in an S*-configuration. The NOESY spectrum also showed correlations of H-6/ H-7 and OH-4/H-2 and with H-12/H3-20, revealing the E-geometry and Z-geometry of C-5/C-6 and C-11/C-12 double bonds, respectively. The remaining stereogenic carbon, C-8, lacked a proton, but there were correlations between H-7/H-17 and H-7/H-9, indicating that C-8 was in an R*-configuration, as evidenced by modeling analysis. Based on the above findings, the relative configurations of stereogenic carbons of 1 were elucidated as 1R*,2S*,4S*,7S*,8R*,9S*,10S*,14S*, and 17R*. As briaranes 14 were isolated along with the known briaranes excavatolide A and briaexcavatolide F [8,9] from the same target organism, the absolute configurations of these two compounds were determined by single-crystal X-ray diffraction analysis [10]. Therefore, it is reasonable on biogenetic grounds to conclude that briaranes 14 have the same absolute configuration as those of excavatolide A and briaexcavatolide F. Based on the above findings, the configurations of the stereogenic carbon of 1 were elucidated as 1R,2S,4S,7S,8R,9S,10S,14S, and 17R (Supplementary Materials, Figures S1–S10).
Briarane 2 (briarenol R) was isolated as an amorphous powder that showed two sodiated adduct ion peaks in (+)-HRESIMS at m/z 519.13912 and 521.13596 (3:1), which accounted for a chlorine atom in the molecular formula, C24H2935ClO9 (calculated for C24H2935ClO9 + Na, 519.13923) (10 degrees of unsaturation). The IR spectrum of 2 showed α,β-unsaturated ketone, ester carbonyl, γ-lactone, and broad OH stretching at 1682, 1742, 1783, and 3455 cm–1, respectively. From the 13C and 1H NMR (Table 1 and Table 2), HSQC, and HMBC spectra (Figure 3), an α,β-unsaturated ketone was deduced from the signals of three carbons at δC 201.6 (C-12), 124.4 (CH-13), and 152.5 (CH-14). The presence of an exocyclic olefin was confirmed by the signal of an sp2 methylene carbon at δC 120.3 (CH2-16) and further supported by two olefin proton signals at δH 5.79 (1H, d, J = 3.0 Hz, H-16a) and 6.06 (1H, d, J = 3.0 Hz, H-16b) in the 1H NMR spectrum. In addition, three carbonyl resonances at δC 173.7 (C-19), 169.6, and 169.3 (2 × ester carbonyls) confirmed the presence of γ-lactone and two ester groups; two acetate methyls (δH 2.23 and 2.27, both 3H × s; δC 20.9 and 21.8, CH3 × 2) were observed. A disubstituted epoxy group was confirmed from the signals of two oxymethine carbons at δC 60.2 (CH-3) and 57.4 (CH-4). The chemical shifts of oxymethine protons at δH 3.48 (1H, dd, J = 9.0, 4.2 Hz, H-3) and 3.67 (1H, d, J = 4.2 Hz, H-4) further confirmed the presence of this group. Based on the 13C NMR data and unsaturated numbers, 2 was established as a tetracyclic briarane. It was observed that the spectroscopic data of 2 resembled those of a known briarane, pachyclavulide D (5) (Figure 1), obtained from the soft coral Pachyclavularia violacea [11]. Comparison of the proton chemical shifts, coupling patterns, and coupling constants for oxymethine protons H-3 (δH 3.38, 1H, dd, J = 9.0, 4.2 Hz) and H-4 (δH 3.67, 1H, d, J = 4.2 Hz) of 2 with those of 5H 3.49, 1H, dd, J = 8.9, 3.7 Hz, H-3; 3.66, 1H, d, J = 3.7 Hz, H-4) [11] indicated the 3,4-epoxide group towards the α-side of the briarane system as that of 5. Furthermore, the 1D and 2D NMR spectra revealed that the signals corresponding to the 11α-hydroxy group in 5 were replaced by those of a proton in 2. Therefore, briarenol R (2) was assigned as having a structure with the same stereochemistry as 5 because of the stereogenic carbons that 2 has in common with 5, as confirmed by correlations observed in the NOESY spectrum (Figure 3). Therefore, the configurations of the stereogenic carbons of 2 were elucidated as 1S,2R,3R,4R,6S, 7R,8R,9S,10S,11R, and 17R (Supplementary Materials, Figures S11–S20).
The molecular formula of briarenol S (3), containing a chlorine atom, was found to be C24H31ClO9 by (+)-HRESIMS at m/z 521.15499 (calculated for C24H3135ClO9, 521.15488). The IR spectrum showed absorptions at 3459 cm–1 due to hydroxy groups at 1777, 1737, and 1678 cm1, due to γ-lactone, ester carbonyl, and α,β-unsaturated ketonic carbonyl groups, respectively. The 13C and 1H NMR spectra (Table 1 and Table 2) disclosed the signals due to five methyls, an sp3 methylene, eight sp3 methines, two sp3 quaternary carbons, an sp2 methylene, two sp2 methines, an sp2 quaternary carbon, and four carbonyl carbons. The low-field ester carbonyl carbon (δC 175.6), coupled with the IR absorption at 1777 cm–1, suggested the presence of a γ-lactone moiety in 3. The high-field ketonic carbonyl carbon at δC 202.4 suggested that the carbonyl group was conjugated with a carbon–carbon double bond. The 1H NMR spectrum (Table 2) showed the signals due to two secondary methyls, a tertiary metyl, two acetate methyls, an aliphatic methylene, three aliphatic methines, a methine bearing a chlorine atom, four oxymethines, an exomethylene, and two olefinic methines. These spectroscopic data, coupled with the degrees of unsaturation (IHDs = 9), suggested that compound 3 is a tricyclic diterpenoid with a γ-lactone, an α,β-unsaturated ketone, an exocyclic olefin, and two acetoxy groups. It was found that the spectroscopic data of 3 were similar to those of a known briarane, solenolide E (6), isolated from a soft coral identified as Solenopodium sp. (= Briareum sp.) [5], collected in the Western Caroline Islands of Palau [12], except that the signals corresponding to one of the C-4 methylene protons in 6 were replaced by signals for an acetoxy group in 3. In the NOESY experiment, H-4 showed a correlation with H-2, revealing that the acetoxy group at C-4 is on the β face in 3. The HMBC and COSY correlations, as shown in Figure 4, provided the gross structure for 3. Hence, briarenol S (3) was found to be the 4β-acetoxy derivative of 6 and the stereochemistry of the stereogenic carbons in 3 was deduced by NOESY analysis (Figure 4), determined as 1S,2S,4R,6S,7R, 8R,9S,10S,11R, and 17R (Supplementary Materials, Figures S21–S31).
Our present study has led to the isolation of a new briarane, briarenol T (4). Its molecular formula C24H32O8 was deduced from (+)-HRESIMS at m/z 471.19879 (calculated for C24H32O8 + Na, 471.19894). The IR spectrum showed absorptions that indicated three different carbonyl types: γ-lactones (νmax 1772 cm−1), esters (νmax 1740 cm–1), and α,β-unsaturated ketones (νmax 1683 cm–1). The latter structural feature was confirmed by the presence of signals at δC 202.6 (C-12), 154.6 (CH-14), and 124.1 (CH-13) in the 13C NMR spectrum (Table 1), and the presence of a mutually coupled pair of doublet signals in the 1H NMR spectrum at δH 5.85 (H-13) and 6.39 (H-14) (J = 10.2 Hz) corresponding to the α- and β-olefinic protons, respectively (Table 2). The spectroscopic data of 4 were similar to those of a known diterpene, cavernulin B (7) (Figure 1), isolated from a sea pen, Cavernularia sp., collected from the Eastern Coast of Bay of Bengal near Digna, India [13], except that the signals corresponding to the 12-hydroxy group in 7 disappeared and were replaced by a ketone group in 4, as assessed by comparing the related spectroscopic data of 4 with those of 7. The locations of functional groups were confirmed by 2D NMR correlations (Figure 5), and hence the structure of briarenol T was assigned as 4, and the configurations of the stereogenic carbons were elucidated as 1S,2S,7S,8R,9S,10S,11R, and 17R (Figure 4) (Supplementary Materials, Figures S32–S41).
The effects of briaranes 14 on the release of iNOS and COX-2 from LPS-stimulated RAW 264.7 macrophage cells were assessed (Table 3). Briaranes 3 and 4 were found to inhibit the release of iNOS to 78.50 and 79.95%, respectively. It is interesting to note that 2 enhanced the expression of COX-2 to 112.96%, as compared to results of the cells stimulated with LPS only (Supplementary Materials, Figure S37).

3. Materials and Methods

3.1. General Experimental Procedures

NMR spectra were recorded on a 600 MHz Jeol ECZ NMR (Jeol, Tokyo, Japan) spectrometer using the residual CHCl3H 7.26 ppm) and CDCl3C 77.1 ppm) signals as internal references for 1H and 13C NMR, respectively. ESIMS and HRESIMS were obtained from the Bruker mass spectrometer with 7 Tesla magnets (model: SolariX FTMS system, Bremen, Germany). Column chromatography, HPLC, IR spectra, and optical rotation were performed according to our earlier research [14].

3.2. Animal Material

Specimens of B. stechei used for this study were collected from an 80 ton culturing tank equipped with a flow-through sea water system located in the National Museum of Marine Biology and Aquarium (NMMBA) at April 2016. Identification of the species of this organism was performed by comparison, as described in previous studies [5,15,16,17]. Living reference specimens are being maintained in the authors’ marine organisms culturing tanks and a voucher specimen was deposited in the NMMBA (voucher no.: NMMBA-TW-GC-2016-031), Taiwan.

3.3. Extraction and Isolation

Sliced bodies (wet/dry weight = 3980/1860 g) of the specimen were grounded and extracted with a mixture of MeOH and CH2Cl2 (1:1) to give an extract (104 g). The extract was then applied to a silica gel column chromatograph (Si C.C.) and eluted with gradients of hexane/EtOAc (stepwise from 50:1−1:2) to furnish fractions A−L. Fractions H and I were combined (19.0 g) and separated on Si C.C. using hexane/EtOAc (stepwise from 50:1, pure EtOAc) to obtain fractions H1−H8. Fraction H6 was chromatographed with Si C.C. using hexane/EtOAc/acetone to obtain fractions H6A−H6K. Fraction H6E was separated by Si C.C. using a mixture of CH2Cl2 and acetone (4:1) to obtain fractions H6E1−H6E6. Fraction H6E2 was repurified by NP-HPLC using a mixture of CH2Cl2 and acetone (8:1; at a flow rate = 2.0 mL/min) to yield fractions H6E2A−H6E2E. Fraction H6E2C was separated by RP-HPLC using a mixture of MeOH and H2O (60:40; at a flow rate = 4.0 mL/min) to obtain 2 (0.6 mg), 4 (0.3 mg), and 1 (0.3 mg), respectively. Fraction H6G was chromatographed on reverse-phase silica gel, using a mixture of acetonitrile and H2O (1:1) to obtain fractions H6G1–H6G5. Fraction H6G3 was repurified by NP-HPLC using a mixture of dichloromethane and acetone (5:1) to yield fractions H6G3A−H6G3D. Fraction H6G3B was separated by NP-HPLC using a mixture of dichloromethane and acetone (8:1) to yield fractions H6G3B1−H6G3B5. Fraction H6G3B5 was separated by RP-HPLC with a mixture of MeOH and H2O (60:40, at a flow rate of 1.0 mL/min) to afford 3 (0.3 mg).
Briarenol Q (1): Amorphous powder; [ α ] D 25 +22 (c 0.1, CHCl3); IR (KBr) νmax 3408, 1783, 1733 cm−1; 13C (150 MHz, CDCl3) and 1H (600 MHz, CDCl3) NMR data, see Table 1 and Table 2; ESIMS: m/z 573 [M + Na]+; HRESIMS: m/z 573.19426 (calculated for C27H34O12 + Na, 573.19425).
Briarenol R (2): Amorphous powder; [ α ] D 22 −55 (c 0.2, CHCl3); IR (KBr) νmax 3455, 1783, 1742, 1682 cm−1; 13C (150 MHz, CDCl3) and 1H (600 MHz, CDCl3) NMR data, see Table 1 and Table 2; ESIMS: m/z 519 [M + Na]+, 521 [M + 2 + Na]+; HRESIMS: m/z 519.13912 (calculated for C24H2935ClO9 + Na, 519.13923).
Briarenol S (3): Amorphous powder; [ α ] D 24 +34 (c 0.1, CHCl3); IR (KBr) νmax 3459, 1777, 1738, 1678 cm−1; 13C (150 MHz, CDCl3) and 1H (600 MHz, CDCl3) NMR data, see Table 1 and Table 2; ESIMS: m/z 521 [M + Na]+, 523 [M + 2 + Na]+; HRESIMS: m/z 521.15499 (calculated for C24H3135ClO9 + Na, 521.15488).
Briarenol T (4): Amorphous powder; [ α ] D 25 −30 (c 0.1, CHCl3); IR (KBr) νmax 3445, 1772, 1740, 1683 cm−1; 13C (150 MHz, CDCl3) and 1H (600 MHz, CDCl3) NMR data, see Table 1 and Table 2; ESIMS: m/z 471 [M + Na]+; HRESIMS: m/z 471.19879 (calculated for C24H32O8 + Na, 471.19894).

3.4. Molecular Mechanics Calculations

The MM2 force field [6] in CHEM3D PRO software from CambridgeSoft Corporation (version 15.0, Cambridge, MA, USA) was used to calculate the molecular models.

3.5. In Vitro Anti-inflammatory Assay

The anti-inflammatory assay was employed to evaluate the activities of briaranes 14 in reducing the release of iNOS and COX-2 from macrophage cells, as the literature reported [18].

4. Conclusions

Four new briaranes, briarenols Q‒T (14), were identified from a cultured-type octocoral B. stechei, which was originally inhabiting and distributed in Taiwanese waters, an area with high biodiversity at the intersection of the Kuroshio current and South China Sea surface current. The structures of compounds 14 were elucidated on the basis of spectroscopic analysis and were further confirmed by consideration of biogenetic grounds with modeling compounds that were isolated from the same target cultured octocoral. Briaranes 3 and 4 displayed promising inhibitory effects on the production of iNOS at a concentration of 10 μM. Compound 1 did not exhibit anti-inflammatory activity in this study; more bioactivity screening should be carried out to discover the pharmaceutical potential of the compounds.

Supplementary Materials

Supplementary Materials are available online at https://www.mdpi.com/1660-3397/18/8/383/s1. ESIMS, HRESIMS, IR, 1D (1H and 13C) and 2D (HSQC, HMBC, COSY, and NOESY) NMR spectra of briarenols Q–T (14).

Author Contributions

Conceptualization, T.-Y.W., C.-Y.C. and P.-J.S.; investigation, Y.-L.Z., C.-C.C., Y.-T.L., Z.-H.W., Y.-C.W., Y.-J.W. and T.-L.H.; writing—original draft preparation, Y.-L.Z., C.-C.C. and P.-J.S.; writing—review and editing, Y.-L.Z., C.-C.C., T.-Y.W., C.-Y.C. and P.-J.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by grants from the National Museum of Marine Biology and Aquarium; the National Dong Hwa University; and the Ministry of Science and Technology, Taiwan (Grant Nos: MOST 106-2320-B-291-001-MY3, 109-2320-B-276-001-MY2, and 109-2320-B-291-001-MY3), awarded to Tung-Ying Wu and Ping-Jyun Sung.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Bergman, W.; Feeney, R.J. The isolation of a new thymine pentoside from sponge. J. Am. Chem. Soc. 1950, 72, 2809–2810. [Google Scholar] [CrossRef]
  2. Rocha, J.; Peixe, L.; Gomes, N.C.M.; Calado, R. Cnidarians as a source of new marine bioactive compounds—an overview of the last decade and future steps for bioprospecting. Mar. Drugs 2011, 9, 1860–1886. [Google Scholar] [CrossRef] [PubMed]
  3. Ćetković, H.; Halasz, M.; Bosnar, M.H. Sponges: A reservoir of genes implicated in human cancer. Mar. Drugs 2018, 16, 20. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Yan, H.-Y. Harvesting drugs from the seas and how Taiwan could contribute to this effort. Changhua J. Med. 2004, 9, 1–6. [Google Scholar]
  5. Samimi-Namin, K.; van Ofwegen, L.P. Overview of the genus Briareum (Cnidaria, Octocorallia, Briareidae) in the Indo-Pacific, with the description of a new species. Zookeys 2016, 557, 1–44. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Allinger, N.L. Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms. J. Am. Chem. Soc. 1977, 99, 8127–8134. [Google Scholar] [CrossRef]
  7. Chen, Y.-H.; Chin, H.-K.; Peng, B.-R.; Chen, Y.-Y.; Hu, C.-C.; Zheng, L.-G.; Huynh, T.-H.; Su, T.-P.; Zhang, Y.-L.; Wen, Z.-H.; et al. Survey of briarane-type diterpenoids–Part VII. Heterocycles 2020, 100, 857–870, and previous review articles in this series. [Google Scholar]
  8. Sheu, J.-H.; Sung, P.-J.; Cheng, M.-C.; Liu, H.-Y.; Fang, L.-S.; Duh, C.-Y.; Chiang, M.Y. Novel cytotoxic diterpenes, excavatolides A–E, isolated from the Formosan gorgonian Briareum excavatum. J. Nat. Prod. 1998, 61, 602–608. [Google Scholar] [CrossRef] [PubMed]
  9. Sheu, J.-H.; Sung, P.-J.; Su, J.-H.; Liu, H.-Y.; Duh, C.-Y.; Chiang, M.Y. Briaexcavatolides A–J, new diterpenes from the gorgonian Briareum excavatum. Tetrahedron 1999, 55, 14555–14564. [Google Scholar] [CrossRef]
  10. Zhang, Y.-L.; Kuo, L.-M.; Chen, L.-Y.; Lee, G.-H.; Peng, B.-R.; Chen, Y.-Y.; Chen, Y.-H.; Hwang, T.-L.; Sheu, J.-H.; Sung, P.-J. Identification and characterization of chlorine-containing briaranes from a cultured octocoral Briareum excavatum. Heterocycles, 2020; submitted. [Google Scholar]
  11. Iwasaki, J.; Ito, H.; Aoyagi, M.; Sato, Y.; Iguchi, K. Briarane-type diterpenoids from the Okinawan soft coral Pachyclavularia violacea. J. Nat. Prod. 2006, 69, 2–6. [Google Scholar] [CrossRef] [PubMed]
  12. Groweiss, A.; Look, S.A.; Fenical, W. Solenolides, new antiinflammatory and antiviral diterpenoids from a marine octocoral of the genus Solenopodium. J. Org. Chem. 1988, 53, 2401–2406. [Google Scholar] [CrossRef]
  13. Patra, A.; Majumdar, A.; Mandal, K.K.; Ghosh, A.; Banerjee, D.; Haldar, B.P. Secondary metabolites from the cnidarian Cavernularia sp.: Structures of the new briaranes cavernulin A and B. J. Indian Chem. Soc. 2001, 78, 619–626. [Google Scholar] [CrossRef]
  14. Lin, C.-C.; Chen, W.-F.; Lee, G.-H.; Wen, Z.-H.; Fang, L.-S.; Kuo, Y.-H.; Lee, C.-Y.; Sung, P.-J. Fragilides M–O, new triacetoxybriaranes from the gorgonian coral Junceella fragilis (Ellisellidae). Heterocycles 2019, 98, 984–994. [Google Scholar]
  15. Bayer, F.M. Key to the genera of octocorallia exclusive of Pennatulacea (Coelenterata: Anthozoa), with diagnoses of new taxa. Proc. Biol. Soc. Wash. 1981, 94, 902–947. [Google Scholar]
  16. Benayahu, Y.; Jeng, M.-S.; Perkol-Finkel, S.; Dai, C.-F. Soft corals (Octocorallia: Alcyonacea) from Southern Taiwan. II. Species diversity and distributional patterns. Zool. Stud. 2004, 43, 548–560. [Google Scholar]
  17. Miyazaki, Y.; Reimer, J.D. Morphological and genetic diversity of Briareum (Anthozoa: Octocorallia) from the Ryukyu Archipelago, Japan. Zool. Sci. 2014, 31, 692–702. [Google Scholar] [CrossRef] [PubMed]
  18. Chen, C.-H.; Chen, N.-F.; Feng, C.-W.; Cheng, S.-Y.; Hung, H.-C.; Tsui, K.-H.; Hsu, C.-H.; Sung, P.-J.; Chen, W.-F.; Wen, Z.-H. A coral-derived compound improves functional recovery after spinal cord injuruy through its antiapoptotic and anti-inflammatory effects. Mar. Drugs 2016, 14, 160. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Structures of briarenols Q–T (14), pachyclavulide D (5), solenolide E (6), cavernulin B (7), and a picture of cultured Briareum stechei.
Figure 1. Structures of briarenols Q–T (14), pachyclavulide D (5), solenolide E (6), cavernulin B (7), and a picture of cultured Briareum stechei.
Marinedrugs 18 00383 g001
Figure 2. Key correlation spectroscopy (COSY; Marinedrugs 18 00383 i001), heteronuclear multiple-bond correlation (HMBC; Marinedrugs 18 00383 i002), and nuclear Overhauser effect spectroscopy (NOESY; Marinedrugs 18 00383 i003) correlations of 1.
Figure 2. Key correlation spectroscopy (COSY; Marinedrugs 18 00383 i001), heteronuclear multiple-bond correlation (HMBC; Marinedrugs 18 00383 i002), and nuclear Overhauser effect spectroscopy (NOESY; Marinedrugs 18 00383 i003) correlations of 1.
Marinedrugs 18 00383 g002
Figure 3. Key COSY ( Marinedrugs 18 00383 i001), HMBC ( Marinedrugs 18 00383 i002), and NOESY ( Marinedrugs 18 00383 i003) correlations of 2.
Figure 3. Key COSY ( Marinedrugs 18 00383 i001), HMBC ( Marinedrugs 18 00383 i002), and NOESY ( Marinedrugs 18 00383 i003) correlations of 2.
Marinedrugs 18 00383 g003
Figure 4. Key COSY ( Marinedrugs 18 00383 i001), HMBC ( Marinedrugs 18 00383 i002), and NOESY ( Marinedrugs 18 00383 i003) correlations of 3.
Figure 4. Key COSY ( Marinedrugs 18 00383 i001), HMBC ( Marinedrugs 18 00383 i002), and NOESY ( Marinedrugs 18 00383 i003) correlations of 3.
Marinedrugs 18 00383 g004
Figure 5. Key COSY ( Marinedrugs 18 00383 i001), HMBC ( Marinedrugs 18 00383 i002), and NOESY ( Marinedrugs 18 00383 i003) correlations of 4.
Figure 5. Key COSY ( Marinedrugs 18 00383 i001), HMBC ( Marinedrugs 18 00383 i002), and NOESY ( Marinedrugs 18 00383 i003) correlations of 4.
Marinedrugs 18 00383 g005
Table 1. The 13C NMR (δC 150 MHz, CDCl3) data for briaranes 14.
Table 1. The 13C NMR (δC 150 MHz, CDCl3) data for briaranes 14.
Position1234
144.3, C a41.1, C43.9, C44.1, C
272.1, CH76.0, CH78.1, CH79.5, CH
341.8, CH260.2, CH34.5, CH231.6, CH2
494.0, C57.4, CH74.2, CH28.9, CH2
5138.4, C133.6, Cn. o. c147.2, C
6128.0, CH60.9, CH62.3, CH118.1, CH
770.1, CH76.3, CH77.2, CH77.7, CH
880.8, C84.2, C85.0, C82.2, C
977.2, CH68.4, CH74.2, CH71.3, CH
1040.7, CH39.2, CH38.8, CH38.3, CH
11131.1, C44.7, CH47.3, CH48.5, CH
12122.0, CH201.6, C202.4, C202.6, C
1328.4, CH2124.4, CH124.5, CH124.1, CH
1471.8, CH152.5, CH155.1, CH154.6, CH
1513.4, CH314.6, CH318.1, CH315.4, CH3
16164.6, C120.3, CH2122.8, CH228.4, CH3
1748.0, CH45.5, CH45.4, CH42.6, CH
188.7, CH36.2, CH37.7, CH36.8, CH3
19174.9, C173.7, C175.6, C175.5, C
2024.2, CH315.6, CH315.3, CH315.0, CH3
OAc-2169.2, C b
21.3, CH3
169.6, C
20.9, CH3
169.8, C
21.0, CH3
168.9, C
21.7, CH3
OAc-4 169.1, C
21.0, CH3
OAc-9169.7, C
21.0, CH3
169.3, C
21.8, CH3
170.2, C
21.1, CH3
OAc-14173.2, C b
21.3, CH3
OCH3-1652.4, CH3
a Multiplicity deduced by 13C and HSQC spectra; b data exchangeable; c n. o. = not obersved.
Table 2. The 1H NMR (δH 600 MHz, CDCl3) data (J in Hz) for briaranes 14.
Table 2. The 1H NMR (δH 600 MHz, CDCl3) data (J in Hz) for briaranes 14.
Position1234
25.11 d (7.2)4.75 d (9.0)4.63 dd (3.6, 3.0)4.44 dd (6.6, 1.2)
2.46 d (16.8) 1.86 ddd (15.6, 3.6, 3.6)1.70 m
β3.40 dd (16.8, 7.2)3.48 dd (9.0, 4.2)3.00 ddd (15.6, 12.0, 3.0)2.75 m
5.81 dd (12.0, 3.6)2.06 ddd (14.4, 14.4, 4.8)
β 3.67 d (4.2)2.54 m
66.84 d (4.8)5.39 m5.29 br s5.44 br d (10.2)
74.44 d (4.8)5.08 d (3.6)5.41 d (3.0)5.23 d (10.2)
96.05 s5.57 d (8.4)3.90 dd (6.0, 6.0)5.30 d (4.8)
103.10 br s2.51 dd (8.4, 4.2)2.67 br s2.69 dd (4.8, 4.2)
11 2.87 qd (7.2, 4.2)2.45 m2.50 qd (7.2, 4.2)
125.56 br s
13α/β2.02 m; 2.38 br d (18.0)5.88 dd (10.2, 0.6)5.89 d (10.2)5.85 d (10.2)
145.18 d (4.2)6.37 d (10.2)6.47 d (10.2)6.39 d (10.2)
151.04 s1.28 s1.46 s1.23 s
16a/b 5.79 d (3.0); 6.06 d (3.0)5.72 s; 5.89 s1.99 d (1.2)
172.79 q (7.2)2.50 q (7.2)3.05 q (7.8)2.44 q (7.2)
181.46 d (7.2)1.25 d (7.2)1.19 d (7.8)1.21 d (7.2)
201.96 br s1.30 d (7.2)1.25 d (7.2)1.32 d (7.2)
OH-46.11 s
OH-8 3.52 s3.42 sn. o. b
OAc-22.04 s a2.23 s2.09 s a2.24 s
OAc-4 2.17 s a
OAc-92.03 s2.27 s 2.13 s
OAc-142.11 s a
OCH3-163.81 s
a Data exchangeable; b n. o. = not observed.
Table 3. Western blotting showed that briaranes 3 and 4 suppressed the expression of iNOS. Data were normalized to the cells treated with LPS only, while cells treated with dexamethasone (Dex) (10 μM) were used as a positive control.
Table 3. Western blotting showed that briaranes 3 and 4 suppressed the expression of iNOS. Data were normalized to the cells treated with LPS only, while cells treated with dexamethasone (Dex) (10 μM) were used as a positive control.
CompoundiNOSCOX-2
Expression (% of LPS) at 10 μM
Control1.28 ± 0.290.76 ± 0.13
LPS100.00 ± 1.87100.00 ± 3.26
198.27 ± 5.1394.00 ± 3.47
284.53 ± 4.66 *112.96 ± 4.54
378.50 ± 3.45 *97.66 ± 4.60
479.95 ± 2.94 *104.66 ± 7.86
Dexamethasone24.56 ± 1.85 *6.56 ± 1.18 *
Data are presented as the mean ± SEM (n = 4); * significantly different from cells treated with LPS (p < 0.05).

Share and Cite

MDPI and ACS Style

Zhang, Y.-L.; Chiang, C.-C.; Lee, Y.-T.; Wen, Z.-H.; Wu, Y.-C.; Wu, Y.-J.; Hwang, T.-L.; Wu, T.-Y.; Chang, C.-Y.; Sung, P.-J. Briarenols Q–T: Briaranes from A Cultured Octocoral Briareum stechei (Kükenthal, 1908). Mar. Drugs 2020, 18, 383. https://doi.org/10.3390/md18080383

AMA Style

Zhang Y-L, Chiang C-C, Lee Y-T, Wen Z-H, Wu Y-C, Wu Y-J, Hwang T-L, Wu T-Y, Chang C-Y, Sung P-J. Briarenols Q–T: Briaranes from A Cultured Octocoral Briareum stechei (Kükenthal, 1908). Marine Drugs. 2020; 18(8):383. https://doi.org/10.3390/md18080383

Chicago/Turabian Style

Zhang, Yi-Lin, Chih-Chao Chiang, Yi-Ting Lee, Zhi-Hong Wen, Yang-Chang Wu, Yu-Jen Wu, Tsong-Long Hwang, Tung-Ying Wu, Chia-Yuan Chang, and Ping-Jyun Sung. 2020. "Briarenols Q–T: Briaranes from A Cultured Octocoral Briareum stechei (Kükenthal, 1908)" Marine Drugs 18, no. 8: 383. https://doi.org/10.3390/md18080383

APA Style

Zhang, Y. -L., Chiang, C. -C., Lee, Y. -T., Wen, Z. -H., Wu, Y. -C., Wu, Y. -J., Hwang, T. -L., Wu, T. -Y., Chang, C. -Y., & Sung, P. -J. (2020). Briarenols Q–T: Briaranes from A Cultured Octocoral Briareum stechei (Kükenthal, 1908). Marine Drugs, 18(8), 383. https://doi.org/10.3390/md18080383

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop